Press release
Impact Of High Pneumonia Prevalence On Vaccine Demand: A Key Factor Shaping the Future of the Vaxneuvance Market in 2025
Impact Of High Pneumonia Prevalence On Vaccine Demand
The market size of vaxneuvance has experienced a $XX (CAGR) growth in recent years. Forecasts show that it will expand from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of $XX%. This growth trajectory in the historic period is attributed to the increasing prevalence of pneumococcal diseases, surge in aging population, elevated levels of supportive regulatory approvals, increased government funding for vaccination, and the rise of travel and globalization.
The market size of vaxneuvance is predicted to witness a surge of $XX (CAGR) in the coming years, escalating to $XX million by 2029 with a compound annual growth rate (CAGR) of $XX%. This expected growth during the forecast period can be ascribed to an increase in chronic diseases, increased antibiotic resistance, heightened respiratory infections in children, a rise in the count of immunocompromised individuals, and increased funding in healthcare. The forthcoming period will see predominant trends like the evolution of needle-free systems for vaccine delivery, advancements in technologies used for cold-chain, incorporation of AI-powered supply chain enhancement, integration into digital health records for immunization tracking, and breakthroughs in adjuvant systems that amplify the immune reaction.
What Are the Main Catalysts for Growth in the Vaxneuvance Market?
The vaxneuvance market is forecasted to expand due to the increasing incidence of pneumonia. Pneumonia, a medical condition characterized by the inflammation of air sacs in either one or both lungs, which may be filled with fluid or pus, can cause symptoms like coughing, fever, and difficulty in breathing. Factors contributing to the rise in pneumonia cases include viral and bacterial infections, compromised immune systems, air pollution, and the growing number of elderly people who are more prone to respiratory infections. Vaxneuvance can aid patients by providing protection against pneumonia due to 15 types of Streptococcus pneumoniae, diminishing the chance of severe infections and associated complications. For example, the Johns Hopkins University, a research university in the US, reported that the average Pneumonia GAPPD (Global Action Plan for Pneumonia and Diarrhea) score across 15 countries rose 2% from 54% to 56% in 2024. Thus, the escalating incidence of pneumonia is propelling the vaxneuvance market's growth.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20428&type=smp
Which Businesses Are at the Forefront of Vaxneuvance Market Development?
Major companies operating in the vaxneuvance market are Merck & Co. Inc.
What Are the Latest Innovations in the Vaxneuvance Market?
A principal trend in the vaxneuvance market is the expansion of vaccine indications to cater to a wider patient base. Enhanced indications fulfill unmet medical requirements and heighten the vaccine's efficacy in battling pneumococcal diseases in various age clusters. For example, Merck & Co. Inc., a pharmaceutical corporation based in the US, declared in June 2022 that the United States Food and Drug Administration (FDA) widened the vaxneuvance approval to children from 6 weeks to 17 years old, to prevent invasive pneumococcal disease from 15 serotypes. Although this approval emphasizes its clinical importance, it warns against usage in individuals with intense allergies to its components.
How Is the Vaxneuvance Market Segmented?
The vaxneuvance market covered in this report is segmented -
1) By Indication: Pneumonia; Meningitis; Sepsis; Bacteremia; Otitis Media
2) By Distribution Channel: Pharmacies; Hospitals
3) By End User: Adults; Children; Geriatric Population
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/vaxneuvance-global-market-report
Where Is the Vaxneuvance Market Growth Most Prominent?
North America was the largest region in the vaxneuvance market in 2024. The regions covered in the vaxneuvance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Vaxneuvance Global Market Report?
- Market Size Analysis: Analyze the vaxneuvance Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the vaxneuvance Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall vaxneuvance market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the vaxneuvance market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20428
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Of High Pneumonia Prevalence On Vaccine Demand: A Key Factor Shaping the Future of the Vaxneuvance Market in 2025 here
News-ID: 3875780 • Views: …
More Releases from The Business research company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Pneumonia
Pneumonia Testing Market: Trends, Opportunities, and Challenges
The global pneumonia testing market is experiencing steady growth, valued at $1.6 billion in 2020 and projected to reach $3.0 billion by 2030, at a CAGR of 6.5% (2021-2030). Pneumonia, a serious respiratory infection, remains a leading cause of morbidity and mortality worldwide. With advancements in diagnostic technologies and increased healthcare awareness, the market for pneumonia testing is expanding rapidly.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3776
Key Market Drivers
• Rise…
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To …
How Are the key drivers contributing to the expansion of the pneumonia therapeutics market?
The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies like…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview
Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills.
Read Report Overview -…
Industry Dynamics of Ventilator-associated Pneumonia
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
